Pharma China (www.pharmachinaonline.com) is the most influential English media and source of business intelligence covering the Chinese pharmaceutical sector. Pharma China caters for the growing needs of the international pharmaceutical industry for up-to-date and insightful information and intelligence on China’s burgeoning but increasingly complex healthcare marketplace, and is subscribed by most MNC pharma companies, leading CROs, investment banks, consulting firms active in China as well as relevant industry associations and government agencies.

Note: To view full text of free articles, you need to register as a basic member first and then log in. To view premium articles, you need to subscribe to Pharma China as a premium member. For more information or subscription, please contact info@pharmachinaonline.com. If you wish to unsubscribe from this e-Alert, please reply this e-mail with "Remove" in the subject line.
Editor´s Picks
Breaking News on New Policies of Innovative Drugs in China(4/19/2018 )  (Premium)
Chinese Money Floods U.S. Biotech as Beijing Chases New Cures(4/18/2018 )  (Premium)
China Announces New Initiatives to Level the Playing Field for Innovative and Generic Drugs(4/18/2018 )  (Premium)
U.S. Businesses Worried over Chinese Policy Initiative(4/17/2018 )  (Premium)
China Will Always Be Bad at Bioethics(4/17/2018 )  (free)
Why Immuno-Therapy Is Leaving Markets Abuzz Across the World(4/17/2018 )  (Premium)
Goldman Sachs: China Is Beating the U.S. in the Gene Editing Arms Race(4/17/2018 )  (Premium)
Industry News
Tocagen Licenses Greater China Rights for Phase III Cancer Immunotherapy to ApolloBio(4/19/2018 )  (Premium)
Pfenex and NT Pharma Agree over Bioequivalent Generic of Forteo(4/19/2018 )  (Premium)
WuXi AppTec Expands Site in the U.S. for Drug Development Testing Services(4/19/2018 )  (free)
Takeda Launches Multiple Myeloma Drug Ninlaro in China(4/18/2018 )  (Premium)
Morphotek Licenses Its Eribulin-Linker Payload To Bliss Bio(4/18/2018 )  (Premium)
Alliance Pharma Sells Chinese JV and Rights of Pregnancy Supplement for GBP 2.9M(4/17/2018 )  (Premium)
China Performance of Korean Pharma Cos Mixed in 2017 with Hanmi and Il-yang Up Sharply(4/17/2018 )  (Premium)
Regulatory News
CDE Releases Two Draft Clinical Guidelines for Public Comments(4/19/2018 )  (Premium)
CNDA Solicits Comments on Clinical Guidelines for Acute Heart Failure Drugs(4/19/2018 )  (Premium)
CNDA Outlines Five Focal Areas of Its Work in 2018(4/18/2018 )  (Premium)
GlobalData: Chinese Pharma Regulatory Reforms to Help Attract Foreign Investment(4/17/2018 )  (Premium)
China to Cut Review Time for Clinical Trial Applications with Plan to Expand Reviewer Force(4/17/2018 )  (Premium)
General Health
China Publishes First Health Management Bluebook(4/18/2018 )  (Premium)
China to Roll Out New Measures to Boost Internet + Healthcare(4/16/2018 )  (Premium)
Product/R&D News
Sinovac Announces Preliminary Results of Phase III Trial on sIPV(4/19/2018 )  (Premium)
BeiGene Presents Clinical Data on Pamiparib in Chinese Patients(4/17/2018 )  (free)
JHL Files Clinical Trial Application for Avastin (Bevacizumab) Biosimilar(4/17/2018 )  (Premium)
Opdivo (Nivolumab) Improves Survival in Pretreated Chinese NSCLC Patients(4/16/2018 )  (Premium)
People in the News
Recent Executive Moves(4/19/2018 )  (Premium)
Other News
China to Set Up Hainan Free Trade Zone, Further Benefiting Medical Tourism(4/16/2018 )  (Premium)
© Wicon International GroupˇˇSupport by: www.heightow.com Home | Site map | Contact Us | Links